These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26965504)

  • 1. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
    Preda L; Conte G; Bonello L; Giannitto C; Travaini LL; Raimondi S; Summers PE; Mohssen A; Alterio D; Cossu Rocca M; Grana C; Ruju F; Bellomi M
    Eur Radiol; 2016 Dec; 26(12):4432-4441. PubMed ID: 26965504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between DW-MRI and
    Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of post-chemoradiotherapy DWI ADC
    Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
    Yoon H; Ha S; Kwon SJ; Park SY; Kim J; O JH; Yoo IR
    Ann Nucl Med; 2021 Mar; 35(3):370-377. PubMed ID: 33554314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
    Wong KH; Panek R; Dunlop A; Mcquaid D; Riddell A; Welsh LC; Murray I; Koh DM; Leach MO; Bhide SA; Nutting CM; Oyen WJ; Harrington KJ; Newbold KL
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):759-767. PubMed ID: 29164301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
    Freihat O; Pinter T; Kedves A; Sipos D; Cselik Z; Repa I; Kovács Á
    Cancer Imaging; 2020 Aug; 20(1):56. PubMed ID: 32771060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
    La TH; Filion EJ; Turnbull BB; Chu JN; Lee P; Nguyen K; Maxim P; Quon A; Graves EE; Loo BW; Le QT
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1335-41. PubMed ID: 19289263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune microenvironment of the gene signature reflecting the standardised uptake value on
    Han S; Oh JS; Kim JS
    Ann Nucl Med; 2021 Jan; 35(1):65-75. PubMed ID: 33044632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma.
    Zhong X; Li L; Yin J; Chen Y; Xin X; Yu L; Tang Y; Zhang J; Li J
    Cancer Imaging; 2023 Oct; 23(1):98. PubMed ID: 37828560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Spatial Relationship between Apparent Diffusion Coefficient and Standardized Uptake Value of
    Sauter AW; Stieltjes B; Weikert T; Gatidis S; Wiese M; Klarhöfer M; Wild D; Lardinois D; Bremerich J; Sommer G
    Contrast Media Mol Imaging; 2017; 2017():8650853. PubMed ID: 29391862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent diffusion coefficient for differentiation between extra-nodal lymphoma and squamous cell carcinoma in the head and neck: a systematic review and meta-analysis.
    Baba A; Kurokawa R; Kurokawa M; Rivera-de Choudens R; Srinivasan A
    Acta Radiol; 2024 May; 65(5):449-454. PubMed ID: 38377681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis.
    Silva FFVE; Caponio VCA; Pérez-Sayáns M; Padín-Iruegas ME; Mascitti M; Chamorro-Petronacci CM; Suaréz-Peñaranda JM; Lorenzo-Pouso AI
    Crit Rev Oncol Hematol; 2024 Jan; 193():104202. PubMed ID: 37989426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
    Hoesseini A; Sewnaik A; van den Besselaar BN; Zhang J; van Leeuwen N; Hardillo JA; Baatenburg de Jong RJ; Offerman MPJ
    BMC Palliat Care; 2024 Feb; 23(1):54. PubMed ID: 38395897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
    Spielvogel CP; Stoiber S; Papp L; Krajnc D; Grahovac M; Gurnhofer E; Trachtova K; Bystry V; Leisser A; Jank B; Schnoell J; Kadletz L; Heiduschka G; Beyer T; Hacker M; Kenner L; Haug AR
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):546-558. PubMed ID: 36161512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study.
    Anzai Y; Chang CP; Rowe K; Snyder J; Deshmukh V; Newman M; Fraser A; Smith K; Date A; Galvao C; Monroe M; Hashibe M
    Radiology; 2023 Apr; 307(2):e212915. PubMed ID: 36625743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen-enhanced MRI assessment of tumour hypoxia in head and neck cancer is feasible and well tolerated in the clinical setting.
    McCabe A; Martin S; Rowe S; Shah J; Morgan PS; Borys D; Panek R
    Eur Radiol Exp; 2024 Mar; 8(1):27. PubMed ID: 38443722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis.
    Yap WK; Hsu KH; Wang TH; Lin CH; Kang CJ; Huang SM; Lin HC; Hung TM; Chang KP; Tsai TY
    Ann Nucl Med; 2024 Aug; 38(8):607-618. PubMed ID: 38724805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images.
    Keek SA; Wesseling FWR; Woodruff HC; van Timmeren JE; Nauta IH; Hoffmann TK; Cavalieri S; Calareso G; Primakov S; Leijenaar RTH; Licitra L; Ravanelli M; Scheckenbach K; Poli T; Lanfranco D; Vergeer MR; Leemans CR; Brakenhoff RH; Hoebers FJP; Lambin P
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34210048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI radiomics in head and neck cancer from reproducibility to combined approaches.
    Corti A; Cavalieri S; Calareso G; Mattavelli D; Ravanelli M; Poli T; Licitra L; Corino VDA; Mainardi L
    Sci Rep; 2024 Apr; 14(1):9451. PubMed ID: 38658630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging findings of granular cell tumours of the head and neck.
    Moon HH; Jin K; Choi YJ; Cho KJ; Lee YS; Lee JH
    Clin Radiol; 2023 Dec; 78(12):e1075-e1080. PubMed ID: 37806818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.